Login / Signup

How to approach clinically discordant FT4 results when changing testing platforms: real-world evidence.

Luca M GiovanellaLeonidas DuntasFederica D'AurizioHedwig KurkaTatjana AmmerChristopher M RankW Edward VisserSjoerd A A van den Berg
Published in: Endocrine (2022)
It is important to verify RIs for FT4 in the laboratory population when changing testing platforms; indirect methods may constitute a convenient tool for this. Applying specific RIs for selected subpopulations should be considered to avoid misinterpretations and inappropriate clinical actions.
Keyphrases